Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-06-08

Clinical Trial Update: Fructans, Lactitol and Lactose in Minimal Hepatic Encephalopathy [NA]

View source ↗

Summary

A clinical trial evaluating fructans, lactitol, and lactose for minimal hepatic encephalopathy in patients with liver cirrhosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fructans
  • Lactitol (lactitol)
  • Lactose

Snippet

Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Conditions: Liver Cirrhosis | NA | Status: COMPLETED